Structure
Volume 5, Issue 9, 15 September 1997, Pages 1209-1218
Journal home page for Structure

Research Article
The crystal structure of bovine bile salt activated lipase: insights into the bile salt activation mechanism

https://doi.org/10.1016/S0969-2126(97)00271-2Get rights and content
Under an Elsevier user license
open archive

Abstract

Background: The intestinally located pancreatic enzyme, bile salt activated lipase (BAL), possesses unique activities for digesting different kinds of lipids. It also differs from other lipases in a requirement of bile salts for activity. A structure-based explanation for these unique properties has not been reached so far due to the absence of a three-dimensional structure.

Results: The crystal structures of bovine BAL and its complex with taurocholate have been determined at 2.8 Å resolution. The overall structure of BAL belongs to the α/β hydrolase fold family. Two bile salt binding sites were found in each BAL molecule within the BAL–taurocholate complex structure. One of these sites is located close to a hairpin loop near the active site. Upon the binding of taurocholate, this loop becomes less mobile and assumes a different conformation. The other bile salt binding site is located remote from the active site. In both structures, BAL forms similar dimers with the active sites facing each other.

Conclusions: Bile salts activate BAL by binding to a relatively short ten-residue loop near the active site, and stabilize the loop in an open conformation. Presumably, this conformational change leads to the formation of the substrate-binding site, as suggested from kinetic data. The BAL dimer observed in the crystal structure may also play a functional role under physiological conditions.

Keywords

α/β hydrolase
bile salt activated lipase
crystal structure
dimerization
enzyme activation
heparin-binding site

Cited by (0)

X Wang and XC Zhang, Crystallography Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, Oklahoma 73104, USA.

C Wang and J Tang, Protein Study Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.

J Tang, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

F Dyda, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 5, Bethesda, Maryland 20892-0580, USA.

E-mail address for XC Zhang (corresponding author): [email protected].